Delivery Order SPE2DB24D2018-SPE2DB24FWRQ8
Award Date 3/1/24
Potential Completion Date 3/4/24
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,484.68 firm fixed-price delivery order is for Orilissa 150 mg tablets, a prescription medication. The contract award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,290.82, is for the delivery of Orilissa 150 mg tablets. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,238.51 fixed-price delivery order is for the drug Orilissa 150mg tablets, a specialty medication. The contract has an ultimate completion date of June 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of pharmaceutical products and medical supplies, specifically Orilissa 150 mg tablets, to the Department of Defense (DoD) and related healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract, valued at $4,097.87, is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- The Defense Logistics Agency awarded a delivery order valued at $7,530.90 to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count packages) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was selected to supply this specialized...
- This federal contract award, valued at $8,620.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 MG TABLET 7S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award, valued at $2,523.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORILISSA 150 mg tablets, a medication used in the treatment of certain medical conditions. The contract has an ultimate completion date of April 1, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Orilissa 150 mg tablets, a prescription medication, with an ultimate completion date of September 12, 2024 and a ceiling value of $2,821.04. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by various...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication Orilissa (Elagolix) 150 mg tablets. The contract has a ceiling value of $3,418.68 and a completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award, valued at $3,522.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of Orilissa 200 mg Tablets, a pharmaceutical product, with a period of performance through November 1, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...